Washington Trust Advisors, Inc. Bristol Myers Squibb CO Transaction History
Washington Trust Advisors, Inc.
- $1.26 Billion
- Q3 2025
A detailed history of Washington Trust Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 4,773 shares of BMY stock, worth $223,424. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,773
Previous 4,875
2.09%
Holding current value
$223,424
Previous $225,000
4.44%
% of portfolio
0.02%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding BMY
# of Institutions
2,717Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...